openPR Logo
Press release

Winter Tire Market Will hit at a CAGR of 3.9% from 2018 to 2028

08-02-2018 04:22 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Winter Tire Market Will hit at a CAGR of 3.9% from 2018 to 2028

According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.

Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.

Request Report Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=719

Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success

Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.

CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.

Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend

Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.

Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.

Request Report Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=719

North America Vocal Biomarker Market: Driven by Government Agencies’ Tie-ups with Voice-Related Companies

Robust healthcare infrastructure, and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma. For example, the U.S. Army entered into a collaboration with researchers from MIT for developing voice-based detection system to diagnose brain injuries.

Fact.MR’s report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Winter Tire Market Will hit at a CAGR of 3.9% from 2018 to 2028 here

News-ID: 1159831 • Views:

More Releases from Fact.MR

Biobanking Market Growing at 6.6% CAGR to Touch US$ US$ 89.5 Billion Valuation by 2033: Fact.MR Report
04-16-2024 | Health & Medicine
Fact.MR
Biobanking Market Growing at 6.6% CAGR to Touch US$ US$ 89.5 Billion Valuation b …
The global biobanking market (バイオバンキング市場) is projected to grow at a strong compound annual growth rate of 6.6% by 2023 to 2033, reaching a sales valuation of US$ 89.5 billion. Globally, China, the UK, and the US are the key markets that biobanking enterprises need to be aware of. By storing and preserving biological samples like blood, tissues, and nucleic acids, biobanking plays a crucial part in improving biomedical and translational
Allergy Care Market Predicted to Reach US$ 40 Billion by 2032, Growing at 6.1% CAGR
Allergy Care Market Predicted to Reach US$ 40 Billion by 2032, Growing at 6.1% C …
With a compound annual growth rate (CAGR) of 6.1%, the global allergy care market is expected to reach a value of over USD 40 billion by 2032, from an estimated USD 22 billion in 2022. In 2022, the global market for allergy care will make up less than 1% of the entire healthcare business. It is projected that the market for allergy treatments would expand quickly throughout the forecast period. According
Content Moderation Solutions Market Projecting US$ 26 Billion Value by 2032, with 10.25% CAGR
Content Moderation Solutions Market Projecting US$ 26 Billion Value by 2032, wit …
The content moderation solutions market worldwide has grown significantly in the last few years, and by the end of the 2022-2032 projection period, it is expected to reach US$ 26 billion. From the data, the global market is expected to grow at a compound annual growth rate (CAGR) of more than 10% during the next ten years. The communications, media, and services sector is expected to deploy the majority of content
Basketball Shoes Market Is Anticipated To Reach US$ 6,907 Million By 2032: Fact.MR Report
Basketball Shoes Market Is Anticipated To Reach US$ 6,907 Million By 2032: Fact. …
The global basketball shoes market is set to enjoy a valuation of US$ 5,291 Million in 2022 and further expand at a CAGR of 2.7% to reach US$ 6,907 Million by the end of 2032. The Basketball Shoes Industry sales study offers a comprehensive analysis on diverse features including production capacities, Basketball Shoes demand, product developments, sales revenue generation and Basketball Shoes market outlook across the globe. market research report by Fact.MR,

All 5 Releases


More Releases for CROs

Global CROs Services Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities. Browse 155 Market Data Tables and 115
Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights   A contract research organization (CRO) is a company that
Contract Research Organization Services (CROs) Market brisk growth 2025
Contract Research Organization Services (CROs): Snapshot Contract Research Organization or CRO is described as an organization which provide assistance and services generally to the pharmaceutical and biotechnology industries in the form of data research, drug tests, clinical trials, post development marketing, and related services for the development of both drugs and medical devices. CROs are available in a vast range from large, international full service organizations to small, niche specialty groups
11-26-2010 | Health & Medicine
CROS NT
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”. Vezzoli’s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be used
11-23-2010 | Health & Medicine
CROS NT
CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS
Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.
07-29-2010 | Health & Medicine
CROS NT
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team